SLN · Silence Therapeutics Plc American Depository Share
View on chartInsiders & Stakes
No transactions found.
Transaction History
No transactions found.
No transactions found.
No transactions found.
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Silence Therapeutics (SLN) receives analyst rating upgrade
An analyst has raised the rating on Silence Therapeutics' American Depository Shares, moving it to a more positive stance. The upgrade reflects confidence in the company's recent developments and may affect market perception. The stock is currently in a low RSI zone, suggesting limited recent trading activity.
Silence Therapeutics (SLN) receives analyst rating upgrade. An analyst has raised the rating on Silence Therapeutics' American Depository Shares, moving it to a more positive stance. The upgrade reflects confidence in the company's recent developments and may affect market perception. The stock is currently in a low RSI zone, suggesting limited recent trading activity.